Injective’s INJ ETF approval opens regulated US access, but trading has not begun

Nasdaq approved Canary Capital’s Staked INJ ETF listing on November 4, 2026, giving Injective’s INJ token a route into the regulated US securities market with potential staking rewards. The Injective ETF approval marks an institutional milestone, but it is not the start of trading. Separately, INJ recovered to around $7.64 , above a closely followed breakout level. Key takeaways Canary Capital’s Staked INJ ETF received Nasdaq listing approval. The fund combines INJ exposure with potential staking rewards. INJ gained approximately 9% over 24 hours to around $7.64. Listing approval and the ETF’s trading launch are separate steps. Injective’s INJ ETF approval opens a regulated investment route With Canary Capital’s Staked INJ ETF , INJ now has its first regulated exchange-traded product available in the United States.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to The Cryptonomist.